Revenue remained stable year-over-year amid capacity constraints, but gross margin and EBITDA reached post-pandemic highs. New production lines, a strong pipeline, and the Prothya exit position the company for accelerated growth and strategic investments.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.